Table 3 Analysis of prognostic factors associated with survival in patients resected for LMGC
From: Surgical treatment of liver metastases of gastric cancer: state of the art
Author year | n | Period | T | N | G | H | DIAM metastases | TIMING | MARGIN | MST | Long-term survivors | Recurrence | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1994 [30] | 21 | + | + | - | - | NA | NA | NA | 18 | 19% (4) | NA | ||
1997 [43] | 21 | - | - | - | + | NA | - | NA | NA | 24% (5) | 76.1% | NA | |
2001 [23] | 17 | 1990-1997 | - | + | + | - | NA | + | + | 16 | 0 | 76% | Na |
2001 [9] | 40 | 1975-1999 | - | - | - | - | - | + | - | 12 | 15% (6) | 75% | 88 |
2001 [45] | 10 | 1979-1999 | - | - | - | - | + | + | NA | 16 | 10% (1) | 80% | 10-240 |
2002 [33] | 15 | 1980-1999 | - | - | - | + | - | + | - | 8.8 | 0 | 90% | na |
2002 [31] | 10 | 1981-1998 | - | - | - | - | - | - | NA | 25 | 20% (2) | 80% | 1-68 |
2002 [28] | 19 | 1986-1999 | - | - | + | + | - | + | NA | 21 | 14% (3) | 74% | Na |
2003 [25] | 22 | 1985-2001 | * | - | - | + | + | - | NA | 24 | 20% (5) | 68% | Na |
2003 [41] | 36 | 1979-2001 | - | Ly | - | + | - | - | - | NA | 11% (4) | 83.3% | NA |
2005 [29] | 11 | 1988-1996 | NA | - | - | NA | - | - | - | 19 | 18% (2) | 80 | Na |
2007 [34] | 42 | 1985-2005 | + | - | - | + | - | - | - | 34 | 20% (8) | 67% | 1-86 |
2007 [44] | 37 | 1990-2005 | + | - | - | + | + | - | - | 31 | 6 % (2) | 81 % | Na |
2008 [24] | 24 | 1988-2002 | - | - | - | - | - | - | + | 19 | 8% (2) | 65% | 1-67 |
2008 [40] | 18 | 1989-2004 | + | - | - | - | - | - | - | NA | 17% (3) | Na | 2-200 |
2008 [37] | 22 | 1995-2005 | 15% (3) | 63.6% | 1-106 | ||||||||
2009 [47] | 17 | 1991-2005 | - | - | - | - | - | - | + | 18 | 25% (4) | 70.5% | 1-117 |
Choi 2010 | 14 | 1986-2007 | - | - | - | - | - | - | - | NA | 8% (1) | 63% | Na |
Tsujmoto 2010 | 17 | 1980-2007 | + | Ly | NA | - | - | - | NA | 34 | 30% (5) | 70% | Na |
Our data | |||||||||||||
2012 | 21 | 1998-2007 | 14.2% (3) | 66% | 6-90 |